The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1/2 dose-escalation and expansion study investigating SAR439859 +/- palbociclib in postmenopausal women with estrogen receptor-positive (ER+)/HER2- metastatic breast cancer.
 
Aditya Bardia
Consulting or Advisory Role - bioTheranostics; Genentech; Genentech/Roche (Inst); Immunomedics; Immunomedics; Immunomedics (Inst); Innocrin Pharma (Inst); Merck; Merck (Inst); Novartis; Novartis (Inst); Pfizer; Pfizer (Inst); Radius Health; Radius Health (Inst); Sanofi; Spectrum Pharmaceuticals
Research Funding - bioTheranostics
 
Hannah M. Linden
Leadership - Evolent (I)
Stock and Other Ownership Interests - Evolent (I)
Consulting or Advisory Role - AstraZeneca; Context Therapeutics; Genomic Health; Syndax
Research Funding - Eisai; GTx (Inst); Sanofi/Aventis (Inst)
 
Gary A. Ulaner
Speakers' Bureau - Sanofi
Patents, Royalties, Other Intellectual Property - GE Healthcare; Genentech; Novartis; Sanofi
 
Sarat Chandarlapaty
Consulting or Advisory Role - Context Therapeutics; Lilly; Novartis; Sermonix Pharmaceuticals
Research Funding - Daiichi Sankyo (Inst); Genentech (Inst); Lilly (Inst); Novartis (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Novartis; Sun Pharma
 
Alice Gosselin
Employment - Sanofi
 
Marina Celanovic
Employment - Sanofi
 
Mario Campone
Honoraria - Menarini; Novartis; Servier
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Lilly (Inst); Menarini; Novartis (Inst); Pfizer (Inst); Sanofi (Inst); SERVIER (Inst)
Speakers' Bureau - Amgen; Novartis
Research Funding - Novartis (Inst)
Travel, Accommodations, Expenses - Novartis
Other Relationship - Roche